Skip to main

The best insulin delivery is a human pancreas

The best insulin delivery is a human pancreas

KPCOP invites the authors to discuss pancreas transplant as a superior glycemic control to continuous glucose monitoring and optimal therapy for appropriately selected patients with diabetes.

  • 2:00 PM - 3:00 PM EDT
  • Virtual, as part of the AST Journal Club Series.

"The best insulin delivery is a human pancreas"
(Clin Transplant. 2023 Apr;37(4):e14920. doi: 10.1111/ctr.14920. Epub 2023 Feb 13.)

In this article:
[The authors] conducted a retrospective analysis of pancreas transplantation...to compare glycemic control post pancreas transplantation with newer therapeutic options. [Based on the 134 patients who underwent pancreas transplantation during the 14-year study period, the authors concluded that] pancreas transplant provides superior glycemic control to continuous glucose monitoring and remains the optimal therapy for appropriately selected patients with diabetes.

Speakers:
- Geoffrey K. Dube, MD • Columbia University/New York-Presbyterian Hospital, New York, NY

Moderator:
- Jonathan A. Fridell, MD • Indiana University School of Medicine, Indianapolis, IN

Contributor:
- Lloyd E. Ratner, MD, MPH • Columbia University/New York-Presbyterian Hospital, New York, NY

Sponsored by AST's Kidney Pancreas Community of Practice (KPCOP). All AST Journal Clubs are free but registration is required to attend live.


Learn more about the AST Journal Club Series

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi